Aligos Therapeutics (ALGS)

Aligos Therapeutics (ALGS) Stock Price & Analysis


ALGS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.84 - $2.41
Previous Close$1.11
Average Volume (3M)394.89K
Market Cap
Enterprise Value-$67.17M
Total Cash (Recent Filing)$125.83M
Total Debt (Recent Filing)$12.57M
Price to Earnings (P/E)-0.5
May 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.25
Shares Outstanding42,940,089
10 Day Avg. Volume63,752
30 Day Avg. Volume394,894
Standard Deviation0.31
Financial Highlights & Ratios
Price to Book (P/B)0.47
Price to Sales (P/S)3.18
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-4.83
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.72
Price Target Upside250.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Aligos Therapeutics’s price range in the past 12 months?
Aligos Therapeutics lowest stock price was $0.84 and its highest was $2.41 in the past 12 months.
    What is Aligos Therapeutics’s market cap?
    Currently, no data Available
    When is Aligos Therapeutics’s upcoming earnings report date?
    Aligos Therapeutics’s upcoming earnings report date is May 08, 2023 which is in 40 days.
      How were Aligos Therapeutics’s earnings last quarter?
      Aligos Therapeutics released its earnings results on Mar 09, 2023. The company reported -$0.51 earnings per share for the quarter, missing the consensus estimate of -$0.5 by -$0.01.
        Is Aligos Therapeutics overvalued?
        According to Wall Street analysts Aligos Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Aligos Therapeutics pay dividends?
          Aligos Therapeutics does not currently pay dividends.
          What is Aligos Therapeutics’s EPS estimate?
          Aligos Therapeutics’s EPS estimate is -$0.47.
            How many shares outstanding does Aligos Therapeutics have?
            Aligos Therapeutics has 39,723,255 shares outstanding.
              What happened to Aligos Therapeutics’s price movement after its last earnings report?
              Aligos Therapeutics reported an EPS of -$0.51 in its last earnings report, missing expectations of -$0.5. Following the earnings report the stock price went down -2.941%.
                Which hedge fund is a major shareholder of Aligos Therapeutics?
                Among the largest hedge funds holding Aligos Therapeutics’s share is Versant Venture Management, LLC. It holds Aligos Therapeutics’s shares valued at 2M.


                  Aligos Therapeutics Stock Smart Score

                  The Aligos Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Aligos Therapeutics

                  Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH).


                  Top 5 ETFs holding ALGS

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold ALGS. The ETFs are listed according to market value of ALGS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Protara Therapeutics
                  Unity Biotechnology
                  MAIA Biotechnology, Inc.

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis